» Articles » PMID: 28013235

Kinase Impact Assessment in the Landscape of Fusion Genes That Retain Kinase Domains: a Pan-cancer Study

Overview
Journal Brief Bioinform
Specialty Biology
Date 2016 Dec 26
PMID 28013235
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Assessing the impact of kinase in gene fusion is essential for both identifying driver fusion genes (FGs) and developing molecular targeted therapies. Kinase domain retention is a crucial factor in kinase fusion genes (KFGs), but such a systematic investigation has not been done yet. To this end, we analyzed kinase domain retention (KDR) status in chimeric protein sequences of 914 KFGs covering 312 kinases across 13 major cancer types. Based on 171 kinase domain-retained KFGs including 101 kinases, we studied their recurrence, kinase groups, fusion partners, exon-based expression depth, short DNA motifs around the break points and networks. Our results, such as more KDR than 5'-kinase fusion genes, combinatorial effects between 3'-KDR kinases and their 5'-partners and a signal transduction-specific DNA sequence motif in the break point intronic sequences, supported positive selection on 3'-kinase fusion genes in cancer. We introduced a degree-of-frequency (DoF) score to measure the possible number of KFGs of a kinase. Interestingly, kinases with high DoF scores tended to undergo strong gene expression alteration at the break points. Furthermore, our KDR gene fusion network analysis revealed six of the seven kinases with the highest DoF scores (ALK, BRAF, MET, NTRK1, NTRK3 and RET) were all observed in thyroid carcinoma. Finally, we summarized common features of 'effective' (highly recurrent) kinases in gene fusions such as expression alteration at break point, redundant usage in multiple cancer types and 3'-location tendency. Collectively, our findings are useful for prioritizing driver kinases and FGs and provided insights into KFGs' clinical implications.

Citing Articles

CCDC6-RET fusion protein regulates Ras/MAPK signaling through the fusion- GRB2-SHC1 signal niche.

Qiu T, Kong Y, Wei G, Sun K, Wang R, Wang Y Proc Natl Acad Sci U S A. 2024; 121(23):e2322359121.

PMID: 38805286 PMC: 11161787. DOI: 10.1073/pnas.2322359121.


FusionNW, a potential clinical impact assessment of kinases in pan-cancer fusion gene network.

Yang C, Kumar H, Kim P Brief Bioinform. 2024; 25(2).

PMID: 38493341 PMC: 10944571. DOI: 10.1093/bib/bbae097.


Receptor tyrosine kinases: biological functions and anticancer targeted therapy.

Zhang N, Li Y MedComm (2020). 2023; 4(6):e446.

PMID: 38077251 PMC: 10701465. DOI: 10.1002/mco2.446.


[Drug Resistance Mechanism and Therapeutic Strategy of Targeted Therapy of 
Non-small Cell Lung Cancer with MET Alterations].

Li S, Zhang X Zhongguo Fei Ai Za Zhi. 2023; 26(9):684-691.

PMID: 37985154 PMC: 10600752. DOI: 10.3779/j.issn.1009-3419.2023.102.33.


FusionPDB: a knowledgebase of human fusion proteins.

Kumar H, Tang L, Yang C, Kim P Nucleic Acids Res. 2023; 52(D1):D1289-D1304.

PMID: 37870473 PMC: 10767906. DOI: 10.1093/nar/gkad920.


References
1.
Chmielecki J, Peifer M, Jia P, Socci N, Hutchinson K, Viale A . Targeted next-generation sequencing of DNA regions proximal to a conserved GXGXXG signaling motif enables systematic discovery of tyrosine kinase fusions in cancer. Nucleic Acids Res. 2010; 38(20):6985-96. PMC: 2978357. DOI: 10.1093/nar/gkq579. View

2.
Ross J, Wang K, Chmielecki J, Gay L, Johnson A, Chudnovsky J . The distribution of BRAF gene fusions in solid tumors and response to targeted therapy. Int J Cancer. 2015; 138(4):881-90. PMC: 5049644. DOI: 10.1002/ijc.29825. View

3.
Kumar-Sinha C, Kalyana-Sundaram S, Chinnaiyan A . Landscape of gene fusions in epithelial cancers: seq and ye shall find. Genome Med. 2015; 7:129. PMC: 4683719. DOI: 10.1186/s13073-015-0252-1. View

4.
Wang J, Duncan D, Shi Z, Zhang B . WEB-based GEne SeT AnaLysis Toolkit (WebGestalt): update 2013. Nucleic Acids Res. 2013; 41(Web Server issue):W77-83. PMC: 3692109. DOI: 10.1093/nar/gkt439. View

5.
Kim P, Yoon S, Kim N, Lee S, Ko M, Lee H . ChimerDB 2.0--a knowledgebase for fusion genes updated. Nucleic Acids Res. 2009; 38(Database issue):D81-5. PMC: 2808913. DOI: 10.1093/nar/gkp982. View